Evidence map›Paper›PMID 26712857›Full record

ArticleSchizophrenia bulletin2016

Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes.

Aristotle N Voineskos, Daniel Felsky, Anne L Wheeler, David J Rotenberg, Melissa Levesque, Sejal Patel, Philip R Szeszko, James L Kennedy, Todd Lencz, Anil K Malhotra

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Psychosis as a continuous phenotype in the general population: the thin line between normality and pathology.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aristotle N VoineskosCampbell Family Mental Health Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; These authors contributed equally to the article. Aristotle.Voineskos@camh.ca.
Daniel FelskyCampbell Family Mental Health Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; These authors contributed equally to the article.
Anne L WheelerCampbell Family Mental Health Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada;
David J RotenbergCampbell Family Mental Health Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada;
Melissa LevesqueCampbell Family Mental Health Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada;
Sejal PatelCampbell Family Mental Health Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada;
Philip R SzeszkoZucker Hillside Hospital, Glen Oaks, NY; Center for Psychiatric Neuroscience, Feinstein Institute, Manhasset, NY.
James L KennedyCampbell Family Mental Health Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada;
Todd LenczZucker Hillside Hospital, Glen Oaks, NY; Center for Psychiatric Neuroscience, Feinstein Institute, Manhasset, NY.
Anil K MalhotraZucker Hillside Hospital, Glen Oaks, NY; Center for Psychiatric Neuroscience, Feinstein Institute, Manhasset, NY.

Funding

Striatal D2/D3 Dopamine receptor availability in first episode schizophreniaP50MH080173 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI KANE, JOHN M · 2008 to 2012
$10.4M
Genetic Variation and Functional Disability in SchizophreniaR01MH079800 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI MALHOTRA, ANIL K · 2007 to 2011
$1.9M
1/3 - Social Processes Initiative in Neurobiology of the Schizophrenia(s)R01MH102324 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI VOINESKOS, ARISTOTLE NICHOLAS · 2014 to 2018
$1.4M
Effects of Maintenance Treatment with Olanzapine vs. Placebo on Brain StructureR01MH099167 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI VOINESKOS, ARISTOTLE NICHOLAS · 2013 to 2017
$1.4M
NIMH NIH HHS P50 MH080173NIMH NIH HHS R01 MH079800NIMH NIH HHS R01 MH099167NIMH NIH HHS R01 MH102324
6 · The paper itself

Abstract

backgroundThere are now over 100 established genetic risk variants for schizophrenia; however, their influence on brain structure and circuitry across the human lifespan are not known.

methodsWe examined healthy individuals 8-86 years of age, from the Centre for Addiction and Mental Health, the Zucker Hillside Hospital, and the Philadelphia Neurodevelopmental Cohort. Following thorough quality control procedures, we investigated associations of established genetic risk variants with heritable neuroimaging phenotypes relevant to schizophrenia, namely thickness of frontal and temporal cortical regions (n = 565) and frontotemporal and interhemispheric white matter tract fractional anisotropy (FA) (n = 530).

resultsThere was little evidence for association of risk variants with imaging phenotypes. No association with cortical thickness of any region was present. Only rs12148337, near a long noncoding RNA region, was associated with white matter FA (splenium of corpus callosum) following multiple comparison correction (corrected p = .012); this single nucleotide polymorphism was also associated with genu FA and superior longitudinal fasciculus FA at p <.005 (uncorrected). There was no association of polygenic risk score with white matter FA or cortical thickness.

conclusionsIn sum, our findings provide limited evidence for association of schizophrenia risk variants with cortical thickness or diffusion imaging white matter phenotypes. When taken with recent lack of association of these variants with subcortical brain volumes, our results either suggest that structural neuroimaging approaches at current resolution are not sufficiently sensitive to detect effects of these risk variants or that multiple comparison correction in correlated phenotypes is too stringent, potentially "eliminating" biologically important signals.

Indexed as

PhenotypeAdolescentAdultAgedAged, 80 and overCerebral CortexChildCohort StudiesDiffusion Magnetic Resonance ImagingFemaleGenome-Wide Association StudyHumansMagnetic Resonance ImagingMaleMiddle AgedMultifactorial Inheritanceasymmetrycortical thicknessDTIimaging geneticspolygenic risk

Identifiers

PMID26712857
PMCPMC4903045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.